Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Journal of Enzyme Inhibition and Medicinal Chemistry|May 29, 2018
Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studiesAdel S El-Azab, Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, et al.European Journal of Medicinal Chemistry|October 4, 2011
Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analoguesHussein I El-Subbagh, Ghada S Hassan, Adel S El-Azab, et al.Bioorganic Chemistry|November 14, 2024
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activitiesAbdelrahman Hamdi, Samar S Tawfik, Ahmed R Ali, et al.Bioorganic Chemistry|November 1, 2025
Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR/VEGFR-2 inhibitionMarwa I Serag, Abdelrahman Hamdi, Eman E Nasr, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2013
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2Ibrahim A Al-Suwaidan, Amer M Alanazi, Adel S El-Azab, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 5, 2020
Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking studyAlaa A-M Abdel-Aziz, Adel S El-Azab, Nawaf A AlSaif, et al.Bioorganic & Medicinal Chemistry|September 15, 2006
Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogsSarah T Al-Rashood, Ihsan A Aboldahab, Mahmoud N Nagi, et al.European Journal of Medicinal Chemistry|July 6, 2010
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking studyAdel S El-Azab, Mohamed A Al-Omar, Alaa A-M Abdel-Aziz, et al.RSC Advances|August 21, 2024
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking studySamar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, et al.Molecular Diversity|June 25, 2026
Thiazolidinedione-triazole hybrids: design, synthesis, and biological evaluation as dual inhibitors of α-amylase and aldose reductase with antioxidant activity for antidiabetic therapyEman E Nasr, Mohamed R Elnagar, Nahed Nasser Eid El-Sayed, et al.Pageof 13